NHS England has named eleven new projects chosen for the latest round of an initiative to develop and spread ideas, equipment and technology that can potentially save lives and money. [...]
Wed, Nov 22, 2017
European regulators have cleared Tesaro's Zejula, offering a new option for the maintenance treatment of certain adults with platinum-sensitive relapsed high grade serous epithelial ovarian, fallopian tube, or primary peritoneal cancer. [...]
Wed, Nov 22, 2017
The UK's Competition and Markets Authority has provisionally ruled that Concordia abused its dominant position to overcharge the NHS by millions of pounds for an essential thyroid drug. [...]
Wed, Nov 22, 2017
ViiV Healthcare's Juluca has been green lighted in the US as the first two-drug regimen for some patients with HIV. [...]
Wed, Nov 22, 2017

 

The Learning  Partnership